Wall Street analyst estimates for Orchestra BioMed Holdings, Inc. (OBIO): consensus price target, buy/hold/sell recommendations and forecasts for revenue, EPS and EBITDA for the upcoming fiscal years.
Orchestra BioMed Holdings, Inc. operates as an innovative company in the biomedical sector. Its leading product candidates are BackBeat Cardiac Neuromodulation Therapy (CNT), designed to manage hypertension, and the Virtue Sirolimus AngioInfusion Balloon (SAB), aimed at treating atherosclerotic artery disease. The company's offerings also encompass FreeHold retractors, which are solutions for minimally invasive surgical procedures.
Valuation Ratios
| Price / Book | 11.92 |
| EV / EBITDA | -5.85 |
| Dividend Yield | 0.00% |
Income Statement (10y)
| Year | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Revenue | $5.7M | -$782000 | $3.5M | $2.8M | $2.6M | $33.5M |
| Cost of Revenue | $145000 | $199000 | $322000 | $186000 | $204000 | $190000 |
| Gross Profit | $5.6M | -$981000 | $3.2M | $2.6M | $2.4M | $33.3M |
| Research & Development | $13.5M | $12.9M | $21.9M | $33.8M | $42.8M | $58.2M |
| Selling, General & Admin | $10.8M | $7.9M | $13.9M | $20.3M | $23.9M | $26.9M |
| Operating Expenses | $24.3M | $20.8M | $35.9M | $54.1M | $66.7M | $85.1M |
| Operating Income | -$18.8M | -$21.8M | -$32.7M | -$51.5M | -$64.3M | -$51.8M |
| EBITDA | -$18.6M | -$21.9M | -$33.4M | -$48.8M | -$60.7M | -$51.2M |
| Interest Expense | 0 | $927000 | 0 | 0 | 0 | $1.1M |
| Pre-tax Income | -$21.4M | -$23.0M | -$33.6M | -$49.1M | -$61.0M | -$52.7M |
| Income Tax | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Income | -$21.4M | -$23.0M | -$33.6M | -$49.1M | -$61.0M | -$52.7M |
| EPS | $-0.01 | $-0.02 | $-1.32 | $-1.48 | $-1.66 | $-1.11 |
| EPS (Diluted) | $-0.01 | $-0.02 | $-1.32 | $-1.48 | $-1.66 | $-1.11 |
| Shares Outstanding (Diluted) | $20.4M | $20.4M | $25.5M | $33.2M | $36.8M | $47.7M |
Price
| Price | $6.01 |
| Market Cap | $360M |
| Exchange | NASDAQ |
| Country | US |
Related companies: AVTX · CRBU · ENTA · EPRX · IVA · IVVD · PRLD
Explore sector: Healthcare · Biotechnology
More sections of OBIO: Overview · Financials · Valuation · Statistics · Technical · Ownership · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks